Health Minister Dr Harsh Vardhan at World Bank Annual Meetings Virtual Event said the private companies with research institutes are expediting trials of vaccine candidates. "To address present and future challenges, public health research agenda for COVID-19 has been escalated to advance the development of an affordable vaccine as well as ensure its equal distribution. Our private companies in partnership with foreign and domestic research institutes are expediting trials of their vaccine candidates. We also plan to leverage an integrated IT platform for managing vaccine distribution," said Dr Harsh Vardhan.
AstraZeneca has resumed the U.S. trial of its experimental COVID-19 vaccine after approval by regulators, and Johnson & Johnson is preparing to resume its trial early next week, the companies said on Friday. Fred Katayama reports.
Union Health Minister Harsh Vardhan said that India is likely to have a Covid vaccine by early next year. Harsh Vardhan made the statement in a meeting of the Group of Ministers (GoM). "Early next year..
Credit: HT Digital Content Duration: 04:05Published